Biostax Corp.
BTAX
$0.01
$0.00111.11%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.22M | -2.28M | -2.36M | -1.59M | -3.69M |
| Total Depreciation and Amortization | 27.60K | 41.00K | 54.40K | 40.60K | 26.80K |
| Total Amortization of Deferred Charges | 10.30K | 10.30K | 10.30K | -- | -- |
| Total Other Non-Cash Items | 849.70K | 891.80K | 1.04M | 336.70K | 2.36M |
| Change in Net Operating Assets | 1.47M | 1.14M | 848.10K | 1.06M | 707.00K |
| Cash from Operations | 136.10K | -196.30K | -408.00K | -153.40K | -600.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -500.00K | -500.00K |
| Cash from Investing | -- | -- | -- | -500.00K | -500.00K |
| Total Debt Issued | -153.30K | 163.70K | 287.50K | 472.50K | 856.50K |
| Total Debt Repaid | -200.00 | -200.00 | -200.00 | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -153.50K | 163.50K | 287.30K | 472.50K | 856.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -10.00K |
| Net Change in Cash | -17.40K | -32.90K | -120.70K | -181.00K | -254.20K |
